Marvell president’s trust sells 10,000 shares

Marvell Technology, Inc. insider activity shows an indirect sale of shares tied to its President and COO, Chris Koopmans.

Rhea-AI Filing Summary

Marvell Technology, Inc. insider activity shows an indirect sale of shares tied to its President and COO, Chris Koopmans. A trust associated with Koopmans sold 10,000 shares of common stock in an open-market transaction at a weighted average price of $110.24 per share, with individual trades ranging from $109.19 to $111.85.

After this planned sale under a Rule 10b5-1 trading plan dated January 5, 2026, the trust’s holdings reported in this filing total 133,870 shares of Marvell common stock, reflecting a partial trim rather than a full exit.

Insider Trade Summary 10b5-1

Net Seller: 10,000 shares

Net Sell 1 txn

Insider Koopmans Chris

Role President and COO

Sold 10,000 shs ($1.10M)

Type	Security	Shares	Price	Value
Sale	Common Stock	10,000	$110.24	$1.10M

Holdings After Transaction: Common Stock — 133,870 shares (Indirect, By Trust)

Footnotes (3)

1. F1. Sales were made pursuant to a 10b5-1 Plan dated January 5, 2026.
2. F2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.19 to $111.85, inclusive. The reporting person undertakes to provide Marvell Technology, Inc. ("Marvell"), any security holder of Marvell, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
3. F3. Shares held by Koopmans Family Trust 3/28/13.

Key Figures

Shares sold: 10,000 shares Weighted average sale price: $110.24 per share Post-transaction holdings: 133,870 shares +2 more

5 metrics

Shares sold 10,000 shares Open-market sale on April 6, 2026

Weighted average sale price $110.24 per share Common stock sale by trust

Post-transaction holdings 133,870 shares Shares held indirectly by trust after sale

Sale price range $109.19–$111.85 per share Range of execution prices across multiple trades

Net share direction 10,000 net shares sold transactionSummary net-sell direction

Key Terms

Rule 10b5-1 Plan, weighted average price, open-market sale, indirect ownership, +1 more

5 terms

Rule 10b5-1 Plan financial

"Sales were made pursuant to a 10b5-1 Plan dated January 5, 2026."

A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.

weighted average price financial

"The price reported is a weighted average price."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

open-market sale financial

"transaction_action": "open-market sale""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

indirect ownership financial

""direct_or_indirect": "I", "nature_of_ownership": "By Trust""

Koopmans Family Trust financial

"Shares held by Koopmans Family Trust 3/28/13."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Marvell (MRVL) report for Chris Koopmans?

Marvell reported that a trust associated with President and COO Chris Koopmans sold 10,000 shares of common stock in an open-market transaction. The sale was executed at a weighted average price of $110.24 per share under a pre-established Rule 10b5-1 trading plan.

At what price were the Marvell (MRVL) shares sold in this Form 4?

The reported weighted average sale price was $110.24 per share. According to the filing, individual trades occurred at prices ranging from $109.19 to $111.85, and the reporting person offered to provide detailed trade breakdowns upon request to the company or regulators.

How many Marvell (MRVL) shares does the trust hold after the sale?

Following the reported transaction, the trust associated with Chris Koopmans holds 133,870 shares of Marvell common stock. This figure reflects the position after selling 10,000 shares and indicates that the transaction represents a partial reduction, not a full disposal of the trust’s stake.

Was the Marvell (MRVL) insider sale by Chris Koopmans pre-planned?

Yes. The filing states that the sales were made pursuant to a Rule 10b5-1 trading plan dated January 5, 2026. Such plans allow insiders to schedule trades in advance, which can make the timing of transactions less indicative of their current market outlook.

Who actually holds the Marvell (MRVL) shares sold in this insider filing?

The shares are held by the Koopmans Family Trust dated March 28, 2013. The transaction is reported as indirect ownership "By Trust," meaning the position is attributed to a family trust associated with Chris Koopmans rather than direct personal holdings in his own name.

What type of transaction was reported in the Marvell (MRVL) Form 4?

The Form 4 reports an open-market sale of common stock, coded as an "S" transaction. It is categorized as a non-derivative transaction, indicating the trust sold existing common shares rather than exercising options or converting other securities into stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/06/2026 - 09:51 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Koopmans Chris

(Last) (First) (Middle)

5488 MARVELL LANE

(Street)

SANTA CLARA CALIFORNIA 95054

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Marvell Technology, Inc. [ MRVL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President and COO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/06/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/06/2026		S		10,000(1)	D	$110.24(2)	133,870	I	By Trust(3)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Sales were made pursuant to a 10b5-1 Plan dated January 5, 2026.

2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.19 to $111.85, inclusive. The reporting person undertakes to provide Marvell Technology, Inc. ("Marvell"), any security holder of Marvell, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

3. Shares held by Koopmans Family Trust 3/28/13.

Remarks:

	Christopher Koopmans by Blair Walters as Attorney-in-Fact	04/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)